Le Lézard
Classified in: Business
Subject: ATY

BLUEBIRD BIO INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of bluebird bio, Inc. - BLUE


NEW ORLEANS, La., July 23, 2021 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into bluebird bio, Inc. (NasdaqGS: BLUE).  

In May 2020, the Company announced its plans to submit an application to the U.S. Food and Drug Administration ("FDA") for its product, LentiGlobin, in the second half of 2021. Then, on November 4, 2020, the Company disclosed that, due to the FDA requiring the Company to provide additional data, it was adjusting the timing of its submission to late 2022.

Thereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period in violation of federal securities laws, which remains ongoing. 

KSF's investigation is focusing on whether bluebird's officers and/or directors breached their fiduciary duties to bluebird's shareholders or otherwise violated state or federal laws. 

If you have information that would assist KSF in its investigation, or have been a long-term holder of bluebird shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nasdaqgs-blue/ to learn more.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. KSF serves a variety of clients ? including public institutional investors, hedge funds, money managers and retail investors ? in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850
1100 Poydras St., Suite 3200
New Orleans, LA 70163

SOURCE Kahn Swick & Foti, LLC


These press releases may also interest you

at 17:05
In accordance with regulatory requirements, Dundee Corporation announces that its wholly owned subsidiary, Dundee Resources Limited has disposed of 16,646,826 common shares ("Shares") of Eurogas International Inc., an independent oil and gas...

at 17:05
Think Research Corporation ("Think" or the "Company"), a company focused on transforming healthcare through digital health software solutions, today announced that it has changed its auditor from MNP LLP (the "Former Auditor") to Ernst & Young LLP...

at 16:55
TimkenSteel Corp. , a leader in high-quality specialty steel, manufactured components and supply chain solutions, and the United Steelworkers (USW) Local 1123 have jointly agreed to extend their contract, which expires on Monday, September 27, 2021....

at 16:53
Kensington Capital Acquisition Corp. II ("Kensington") and Wall Box Chargers, S.L. ("Wallbox") today announced that they have determined the exchange ratio to be 240.990816528527 as of the anticipated date for Closing (as defined below) in...

at 16:45
Direxion has announced it will execute forward share splits for two of its exchange-traded funds ("ETFs"), as well as reverse share splits for an additional two ETFs. The total market value of the shares outstanding will not be affected as a result...

at 16:45
Weidai Ltd. (the "Company" or "Weidai") , a leading auto-backed financing solution provider in China, today announced that it has received a letter from the New York Stock Exchange (the "NYSE") dated August 31, 2021, notifying Weidai that it is below...



News published on 23 july 2021 at 22:50 and distributed by: